[Corrigendum] Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer
Na Liu, Shu-Min Peng, Guang-Xi Zhan, Jing Yu, Wei-Min Wu, Hao Gao, Xiao-Feng Li, Xiao-Qing Guo
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMechanisms of cancer metastasis · Ovarian cancer diagnosis and treatment
Oncol Rep 38: 1464–1472, 2017; DOI: 10.3892/or.2017.5818
Following the publication of the above article, an interested reader drew to the Editor's attention that, for the scratch-wound assay experiments shown in Fig. 3 on p. 1468, the “ES-2 LV-β-hCG” and “ES-2 siRNA-β-hCG” data panels were apparently the same, suggesting that the same data panel had erroneously been included twice in this figure. Furthermore, β-actin blots featured in Fig. 2C on p. 1467, and certain of the western blot data featured in Fig. 6A on p. 1470, were strikingly similar to western blot data that appeared in papers subsequently published by the same research group in the journals Cell Cycle and Cancer Science, respectively; finally, the same western blot data had been selected to represent β-catenin and Slug protein bands in Fig. 6A.
After having examined their original data, the authors realized that these figures had been inadvertently assembled incorrectly. The revised versions of Fig. 2 (showing all the correct β-actin data in Fig. 2C), Fig. 3 (showing the correct data for the “ES-2 siRNA-β-hCG” experiment) and Fig. 6 (showing the correct data for the “Slug/ES-2 siRNA-β-hCG” and “Slug/SKOV3 siRNA-β-hCG” protein bands) are shown on the next two pages. Note that the revisions made to these figures do not affect the overall results and conclusions reported in the paper. The authors are grateful to the Editor of Oncology Reports for granting them the opportunity to publish this corrigendum, and all the authors agree with its publication; furthermore, they apologize to the readership of the journal for any inconvenience caused.